Browse by Uncontrolled Keywords
Number of items: 5.
Bibliographic data only
Barnett, AH;
Millar, HL;
Loze, J.-, Y;
L'Italien, GJ;
van Baardewijk, M;
Knapp, M;
(2009)
UK cost-consequence analysis of aripiprazole in schizophrenia: diabetes and coronary heart disease risk projections (STAR study).
European archives of psychiatry and clinical neuroscience, 259 (4).
pp. 239-247.
ISSN 0940-1334
DOI: https://doi.org/10.1007/s00406-008-0863-2
Full text not available from this repository.
Cohen, A;
Gureje, O;
(2007)
Making sense of evidence.
International review of psychiatry (Abingdon, England), 19 (5).
pp. 583-591.
ISSN 0954-0261
DOI: https://doi.org/10.1080/09540260701564880
Full text not available from this repository.
Lynch, J;
Morrison, J;
Graves, N;
Meddis, D;
Drummond, MF;
Hellewell, JSE;
(2001)
The health economic implications of treatment with quetiapine: an audit of long-term treatment for patients with chronic schizophrenia.
European psychiatry, 16 (5).
pp. 307-12.
ISSN 0924-9338
https://researchonline.lshtm.ac.uk/id/eprint/17053
Full text not available from this repository.
Meltzer, H;
Gill, B;
Hinds, K;
Petticrew, M;
(2003)
The prevalence of psychiatric morbidity among adults living in institutions.
International review of psychiatry (Abingdon, England), 15 (1-2).
pp. 129-33.
ISSN 0954-0261
DOI: https://doi.org/10.1080/0954026021000046047
Full text not available from this repository.
Public
Priebe, S;
Reininghaus, U;
McCabe, R;
Burns, T;
Eklund, M;
Hansson, L;
Junghan, U;
Kallert, T;
van Nieuwenhuizen, C;
Ruggeri, M;
+2 more...
Slade, M;
Wang, DL;
(2010)
Factors influencing subjective quality of life in patients with schizophrenia and other mental disorders: A pooled analysis.
Schizophrenia research, 121 (1-3).
pp. 251-258.
ISSN 0920-9964
DOI: https://doi.org/10.1016/j.schres.2009.12.020